A study published last Sunday in the New England Journal of Medicine is receiving ample response from omega-3 industry organizations. Using a population cohort of nearly 5,000 people who supplemented with omega-3-enriched margerines for 40 months, researchers behind the study concluded that 'Low doses of omega-3 fatty acids did not significantly reduce the rates of cardiovascular end points.' This was determined to be the case with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA).
A study published last Sunday in the New England Journal of Medicine is receiving ample response from omega-3 industry organizations.
Using a population cohort of nearly 5,000 people who supplemented with omega-3-enriched margerines for 40 months, researchers behind the study concluded that 'Low doses of omega-3 fatty acids did not significantly reduce the rates of cardiovascular end points.'ÃÂ This was determined to be the case with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA).
The Global Organization for EPA and DHA Omega-3 (GOED; Salt Lake City) has since responded to the study, noting several factors that may have influenced the negative results.
'The study...s authors have stated that such findings may have been affected by multiple unique variables, most notable the administration of cholesterol- and blood pressure-lowering treatments to all subjects during the study...s duration,'ÃÂ said GOED in a recent press release.
GOED also cites the 'relatively low daily dose'ÃÂ of EPA and DHA which was used. 'While 400 mg of combined EPA/DHA provides a sufficient dose for most healthy individuals, previous clinical studies in individuals having suffered a heart attack suggest that 1,000 mg+ of EPA/DHA decreases the incidence of secondary cardiovascular,'ÃÂ said GOED.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.
Continuing innovation in algae-DHA: Natural Products Expo West 2024 Report
March 26th 2024At this year’s Natural Products Expo West, two brands have launched their own versions of algae DHA ingredients; FrieslandCampina and Aker BioMarine. Each brand showcased a different approach to the ingredient.